- F.D.A. Approves Ozempic to Treat Kidney Disease The New York Times
- FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients CNN
- FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use CNBC
- US FDA approves Novo Nordisk’s Ozempic to cut risk of diabetic kidney disease progression Reuters
- Ozempic’s FDA Approval Just Sent Shockwaves Through the Kidney Disease Market Yahoo Finance